Rubedo Life Sciences mission is to treat age-related diseases to extend health-span targeting senescence and stem cells. Founded by Julian Klein, Marco Quarta, and Mark Gallop in 2018, Rubedo Life Sciences is backed by investors that include Khosla Ventures, The Longevity Fund, Shanda Group, Refactor Capital and is headquartered in Sunnyvale.
FOUNDED:
2018
INDUSTRY:
Biotechnology, Health Care
FOUNDERS:
Julian Klein, Marco Quarta, Mark Gallop
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
